Skip to main content
FinSpry Logo
FinSpry
STOK logo
STOK
(NASDAQ)
Stoke Therapeutics, Inc.
$29.65-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Stoke Therapeutics (STOK) Stock Price & Financial Analysis

Stoke Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$28.33 - $29.79
52-Week High$40.22
52-Week Low$12.25
Open$28.45
Volume666.96K
Average Volume (3M)900.10K
Market Cap1.87B
Shares Outstanding63.06M
Price to Sales (P/S)58.29
Price to Book (P/B)4.74
EV/EBITDA-9.75
Revenue (TTM)32.08M
Net Income (TTM)-169.77M
Free Cash Flow (TTM)-147.69M
EPS (TTM)$-2.85
Profit Margin-529.20%
Operating Margin-577.46%
Return on Equity (ROE)-42.99%
Debt to Equity0.01
50-Day MA$30.47
200-Day MA$31.65
52-Week Change107.78%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Stoke Therapeutics

What is the current stock price for STOK?

As of the latest trading session, STOK stock trades at $29.65. The 52-week range is $12.25–$40.22, with a day range of $28.33–$29.79.

What is the P/E ratio for STOK?

The P/E ratio (Price-to-Earnings) for STOK is shown in the Key Statistics section. This valuation metric helps compare Stoke Therapeutics, Inc. to industry peers.

Does STOK pay dividends?

Stoke Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for STOK?

Based on 9 analysts, the consensus for STOK is Buy.

What is the market cap of STOK?

Stoke Therapeutics's market capitalization is $1.87B, classifying it as a small-cap company. Stoke Therapeutics operates in the Healthcare sector within the Biotechnology industry.